Gefapixant Leads to Modest Improvements in Cough
MONDAY, Sept. 11, 2023 (HealthDay News) — For adults with refractory or unexplained chronic cough, gefapixant leads to modest improvement in cough frequency, severity, and quality of life, according to a review published online Sept. 11 in the Journa…
Learn MoreRisk for Death, Cardiovascular Death Lower for OSA Patients Using CPAP
MONDAY, Sept. 11, 2023 (HealthDay News) — For patients with obstructive sleep apnea (OSA), use of continuous positive airway pressure (CPAP) offers cardiovascular (CV) benefits, according to two studies presented at the European Respiratory Society I…
Learn MoreIncrease Seen in COPD Hospital Admissions Since 2010 in Canada
MONDAY, Sept. 11, 2023 (HealthDay News) — The number of hospital admissions for chronic obstructive pulmonary disease (COPD) has increased rapidly since 2010 in Canada, according to a study published online Sept. 11 in CMAJ, the journal of the Canadi…
Learn MoreOpioids Can Be Continued in Cancer Patients With Nonmedical Stimulant Use
MONDAY, Sept. 11, 2023 (HealthDay News) — For patients with cancer-related pain and nonmedical stimulant use, opioids should be continued, monitoring increased, and tapering avoided, according to a study published online Sept. 11 in Cancer.Katie Fitz…
Learn MoreHeat Exposure During Pregnancy Linked to Severe Maternal Morbidity
MONDAY, Sept. 11, 2023 (HealthDay News) — Long- and short-term heat exposure during pregnancy is associated with an increased risk for severe maternal morbidity (SMM), according to a study published online Sept. 7 in JAMA Network Open.Anqi Jiao, from…
Learn MoreSeverity Reduced With Mpox Reinfection, Postvaccination Infection
MONDAY, Sept. 11, 2023 (HealthDay News) — The clinical features and outcomes of mpox reinfection and infection postvaccination are less clinically severe than initial infection, according to a global case series published online Sept. 4 in The Lancet…
Learn MoreLink Explored for NSAID Use, Hormonal Contraception, VTE Risk
MONDAY, Sept. 11, 2023 (HealthDay News) — In women of reproductive age, nonsteroidal anti-inflammatory drug (NSAID) use is associated with venous thromboembolism, with significantly more additional events with concomitant use of high-/medium- versus …
Learn More